@phdthesis{Hellinger2003,
  author    = {Hellinger, Michaela},
  title     = {Untersuchung der Lebensqualit{\"a}t nach operativer Behandlung von Oropharynx- und Mundh{\"o}hlenkarzinomen},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-6543},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2003},
  abstract  = {Die Ergebnisse dieser Studie geben einen {\"U}berblick {\"u}ber den Gesundheitszustand und die Lebensqualit{\"a}t der Patienten nach der operativen Therapie eines Oropharynx- oder Mundh{\"o}hlenkarzinomes. Die Lebensqualit{\"a}t des Einzelnen ist ein komplexes Konstrukt und von den individuellen Werten und Einsch{\"a}tzungen des Patienten abh{\"a}ngig. Die Gesamtwerte des Patientenkollektives k{\"o}nnen nur gemeinsame Tendenzen beschreiben. Insgesamt wurde die Lebensqualit{\"a}t als wenig beeintr{\"a}chtigt eingesch{\"a}tzt. Die Betrachtung der Einzelwerte ergaben jedoch f{\"u}r 50\% der Befragten eine m{\"a}ßige Reduktion der Lebensqualit{\"a}t und des Gesundheitsstatus. Die epidemiologischen und {\"a}tiologischen Faktoren konnten best{\"a}tigt werden. Die Patienten reagierten nach der Operation in Bezug auf die Risikofaktoren einsichtig und verneinten den Alkohol- und Zigarettenkonsum oder schr{\"a}nkten ihn stark ein. Die Aufkl{\"a}rung und die Wiederentscheidung f{\"u}r die einzelnen Therapiearten wurde von den Patienten positiv beurteilt. Hier zeigte die Studie ein hohes Maß an Akzeptanz der postoperativ auftretenden somatischen Einschr{\"a}nkungen, wodurch die subjektive Bewertung der Lebensqualit{\"a}t positiv beeinflusst wurde. Zu den stark lebensqualit{\"a}tsmindernden Symptomen geh{\"o}rten die Xerostomie und die Dysphagie. Die Speisen mussten stark zerkleinert und verfl{\"u}ssigt werden, damit ein Schlucken m{\"o}glich war. Die erschwerte Nahrungsaufnahme kann die Anwendung von oraler Zusatzern{\"a}hrung und den Gebrauch einer Ern{\"a}hrungssonde erfordern, um einen ausreichenden Ern{\"a}hrungszustand zu gew{\"a}hrleisten. Der Gebrauch einer Ern{\"a}hrungssonde wirkte eher lebensqualit{\"a}tsmindernd, als die regelm{\"a}ßige orale Einnahme von kommerziellen fl{\"u}ssigen Formulardi{\"a}ten. Auch die Einschr{\"a}nkung der Bewegungsfreiheit des Kopfes und des Armes als Folge der Neck-dissection geh{\"o}rte mit zu den st{\"a}rker mindernden Faktoren. Der Vergleich h{\"o}herer zu niedrigerer subjektiv empfundener Lebensqualit{\"a}t und Gesundheitsstatus l{\"a}ßt die Annahme zu, dass Patienten, die durch allgemeine Schw{\"a}che und Schmerzen, sowie einer dauerhaften Schmerzmitteleinnahme t{\"a}glich an ihre Erkrankung erinnert werden, ihren Gesundheitsstatus und ihre Lebensqualit{\"a}t als st{\"a}rker vermindert einsch{\"a}tzen.},
  language  = {de}
}
@article{LinzBrandsKertelsetal.2021,
  author    = {Linz, Christian and Brands, Roman C. and Kertels, Olivia and Dierks, Alexander and Brumberg, Joachim and Gerhard-Hartmann, Elena and Hartmann, Stefan and Schirbel, Andreas and Serfling, Sebastian and Zhi, Yingjun and Buck, Andreas K. and K{\"u}bler, Alexander and Hohm, Julian and Lapa, Constantin and Kircher, Malte},
  title     = {Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [\(^{18}\)F]FDG PET/CT and MRI},
  series = {European Journal of Nuclear Medicine and Molecular Imaging},
  volume    = {48},
  journal   = {European Journal of Nuclear Medicine and Molecular Imaging},
  number    = {12},
  issn      = {1619-7070},
  doi       = {10.1007/s00259-021-05422-z},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-307246},
  pages     = {3951-3960},
  year      = {2021},
  abstract  = {Purpose While [\(^{18}\)F]-fluorodeoxyglucose ([\(^{18}\)F]FDG) is the standard for positron emission tomography/computed tomography (PET/CT) imaging of oral squamous cell carcinoma (OSCC), diagnostic specificity is hampered by uptake in inflammatory cells such as neutrophils or macrophages. Recently, molecular imaging probes targeting fibroblast activation protein α (FAP), which is overexpressed in a variety of cancer-associated fibroblasts, have become available and might constitute a feasible alternative to FDG PET/CT. Methods Ten consecutive, treatment-na{\"i}ve patients (8 males, 2 females; mean age, 62 ± 9 years) with biopsy-proven OSCC underwent both whole-body [\(^{18}\)F]FDG and [\(^{68}\)Ga]FAPI-04 (FAP-directed) PET/CT for primary staging prior to tumor resection and cervical lymph node dissection. Detection of the primary tumor, as well as the presence and number of lymph node and distant metastases was analysed. Intensity of tracer accumulation was assessed by means of maximum (SUV\(_{max}\)) and peak (SUV\(_{peak}\) standardized uptake values. Histological work-up including immunohistochemical staining for FAP served as standard of reference. Results [\(^{18}\)F]FDG and FAP-directed PET/CT detected all primary tumors with a SUVmax of 25.5 ± 13.2 (FDG) and 20.5 ± 6.4 (FAP-directed) and a SUVpeak of 16.1 ± 10.3 ([\(^{18}\)F]FDG) and 13.8 ± 3.9 (FAP-directed), respectively. Regarding cervical lymph node metastases, FAP-directed PET/CT demonstrated comparable sensitivity (81.3\% vs. 87.5\%; P = 0.32) and specificity (93.3\% vs. 81.3\%; P = 0.16) to [\(^{18}\)F]FDG PET/CT. FAP expression on the cell surface of cancer-associated fibroblasts in both primary lesions as well as lymph nodes metastases was confirmed in all samples. Conclusion FAP-directed PET/CT in OSCC seems feasible. Future research to investigate its potential to improve patient staging is highly warranted.},
  language  = {en}
}
@article{PolatKaiserWohllebenetal.2017,
  author    = {Polat, B{\"u}lent and Kaiser, Philipp and Wohlleben, Gisela and Gehrke, Thomas and Scherzad, Agmal and Scheich, Matthias and Malzahn, Uwe and Fischer, Thomas and Vordermark, Dirk and Flentje, Michael},
  title     = {Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer},
  series = {BMC Cancer},
  volume    = {17},
  journal   = {BMC Cancer},
  number    = {6},
  doi       = {10.1186/s12885-016-3024-4},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-157529},
  year      = {2017},
  abstract  = {Background: In head and neck cancer little is known about the kinetics of osteopontin (OPN) expression after tumor resection. In this study we evaluated the time course of OPN plasma levels before and after surgery. Methods: Between 2011 and 2013 41 consecutive head and neck cancer patients were enrolled in a prospective study (group A). At different time points plasma samples were collected: T0) before, T1) 1 day, T2) 1 week and T3) 4 weeks after surgery. Osteopontin and TGFβ1 plasma concentrations were measured with a commercial ELISA system. Data were compared to 131 head and neck cancer patients treated with primary (n = 42) or postoperative radiotherapy (n = 89; group B1 and B2). Results: A significant OPN increase was seen as early as 1 day after surgery (T0 to T1, p < 0.01). OPN levels decreased to base line 3-4 weeks after surgery. OPN values were correlated with postoperative TGFβ1 expression suggesting a relation to wound healing. Survival analysis showed a significant benefit for patients with lower OPN levels both in the primary and postoperative radiotherapy group (B1: 33 vs 11.5 months, p = 0.017, B2: median not reached vs 33.4, p = 0.031). TGFβ1 was also of prognostic significance in group B1 (33.0 vs 10.7 months, p = 0.003). Conclusions: Patients with head and neck cancer showed an increase in osteopontin plasma levels directly after surgery. Four weeks later OPN concentration decreased to pre-surgery levels. This long lasting increase was presumably associated to wound healing. Both pretherapeutic osteopontin and TGFβ1 had prognostic impact.},
  language  = {en}
}
@article{WohllebenScherzadGuettleretal.2015,
  author    = {Wohlleben, Gisela and Scherzad, Agmal and G{\"u}ttler, Antje and Vordermark, Dirk and Kuger, Sebastian and Flentje, Michael and Polat, Buelent},
  title     = {Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines},
  series = {Radiation Oncology},
  volume    = {10},
  journal   = {Radiation Oncology},
  number    = {167},
  doi       = {10.1186/s13014-015-0473-x},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-125746},
  year      = {2015},
  abstract  = {Background Tumor hypoxia is a known risk factor for reduced response to radiotherapy. The evaluation of noninvasive methods for the detection of hypoxia is therefore of interest. Osteopontin (OPN) has been discussed as an endogenous hypoxia biomarker. It is overexpressed in many cancers and is involved in tumor progression and metastasis. Methods To examine the influence of hypoxia and irradiation on osteopontin expression we used different cell lines (head and neck cancer (Cal27 and FaDu) and glioblastoma multiforme (U251 and U87)). Cells were treated with hypoxia for 24 h and were then irradiated with doses of 2 and 8 Gy. Osteopontin expression was analyzed on mRNA level by quantitative real-time RT-PCR (qPCR) and on protein level by western blot. Cell culture supernatants were evaluated for secreted OPN by ELISA. Results Hypoxia caused an increase in osteopontin protein expression in all cell lines. In Cal27 a corresponding increase in OPN mRNA expression was observed. In contrast the other cell lines showed a reduced mRNA expression under hypoxic conditions. After irradiation OPN mRNA expression raised slightly in FaDu and U87 cells while it was reduced in U251 and stable in Cal27 cells under normoxia. The combined treatment (hypoxia and irradiation) led to a slight increase of OPN mRNA after 2 Gy in U251 (24 h) and in U87 (24 and 48 h) cell lines falling back to base line after 8 Gy. This effect was not seen in Cal27 or in FaDu cells. Secreted OPN was detected only in the two glioblastoma cell lines with reduced protein levels under hypoxic conditions. Again the combined treatment resulted in a minor increase in OPN secretion 48 hours after irradiation with 8 Gy. Conclusion Osteopontin expression is strongly modulated by hypoxia and only to a minor extent by irradiation. Intracellular OPN homeostasis seems to vary considerably between cell lines. This may explain the partly conflicting results concerning response prediction and prognosis in the clinical setting.},
  language  = {en}
}